Literature DB >> 25939692

The etiology of cirrhosis is a strong determinant of brain reserve: A multimodal magnetic resonance imaging study.

Vishwadeep Ahluwalia1, James B Wade2, F Gerard Moeller2, Melanie B White1, Ariel B Unser1, Edith A Gavis1, Richard K Sterling1, R Todd Stravitz1, Arun J Sanyal1, Mohammad S Siddiqui1, Puneet Puri1, Velimir Luketic1, Douglas M Heuman1, Michael Fuchs1, Scott Matherly1, Jasmohan S Bajaj1.   

Abstract

Poor brain reserve in alcoholic cirrhosis could worsen insight regarding disease severity and increase the patients' vulnerability toward further deterioration. The aim of this study was to analyze brain reserve in abstinent alcoholic cirrhotic (Alc) patients compared to nonalcoholic cirrhotic (Nalc) patients in the context of hepatic encephalopathy (HE) and to evaluate relative change in brain reserve between groups over time and before and after elective transjugular intrahepatic portosystemic shunt (TIPS) placement. The cross-sectional study included 46 Alc and 102 Nalc outpatients with or without HE. Cognitive tests were followed by magnetic resonance imaging (MRI), including proton magnetic resonance spectroscopy (1 H-MRS), diffusion tensor imaging, and T1-weighted imaging. The prospective study included 1H-MRS on a subset of 10 patients before and after TIPS placement. Another subset of 26 patients underwent (1) H-MRS at least 1 year apart. For the cross-sectional study, Alc patients were worse on cognitive tests than Nalc patients. MRI results suggest a greater effect of hyperammonemia, brain edema, and significantly higher cortical damage in Alc as compared to Nalc patients. The effect of HE status on cognitive tests and brain reserve was more marked in the Nalc than in the Alc group. For the TIPS study, Nalc patients showed a greater adverse relative change after TIPS compared to the Alc group. At 1-year follow-up, both groups remained stable between the 2 visits. However, Alc patients continued to show poor brain reserve compared to Nalc patients over time. In conclusion, Alc patients, despite abstinence, have a poor brain reserve, whereas Nalc patients have a greater potential for brain reserve deterioration after HE and TIPS. Information regarding the brain reserve in cirrhosis could assist medical teams to refine their communication and monitoring strategies for different etiologies.
© 2015 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2015        PMID: 25939692      PMCID: PMC4550553          DOI: 10.1002/lt.24163

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  29 in total

1.  Improved optimization for the robust and accurate linear registration and motion correction of brain images.

Authors:  Mark Jenkinson; Peter Bannister; Michael Brady; Stephen Smith
Journal:  Neuroimage       Date:  2002-10       Impact factor: 6.556

Review 2.  Cognitive reserve and Alzheimer disease.

Authors:  Yaakov Stern
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Jul-Sep       Impact factor: 2.703

Review 3.  The neurotoxicity of alcohol.

Authors:  Clive Harper
Journal:  Hum Exp Toxicol       Date:  2007-03       Impact factor: 2.903

4.  Disruption of brain white matter microstructure by excessive intracellular and extracellular fluid in alcoholism: evidence from diffusion tensor imaging.

Authors:  Adolf Pfefferbaum; Edith V Sullivan
Journal:  Neuropsychopharmacology       Date:  2005-02       Impact factor: 7.853

5.  Neuroimaging of gender differences in alcohol dependence: are women more vulnerable?

Authors:  K Mann; K Ackermann; B Croissant; G Mundle; H Nakovics; A Diehl
Journal:  Alcohol Clin Exp Res       Date:  2005-05       Impact factor: 3.455

6.  Deformation-based morphometry of brain changes in alcohol dependence and abstinence.

Authors:  Valerie A Cardenas; Colin Studholme; Stefan Gazdzinski; Timothy C Durazzo; Dieter J Meyerhoff
Journal:  Neuroimage       Date:  2006-11-28       Impact factor: 6.556

Review 7.  Brain reserve hypothesis in dementia.

Authors:  Laura Fratiglioni; Hui-Xin Wang
Journal:  J Alzheimers Dis       Date:  2007-08       Impact factor: 4.472

8.  Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy.

Authors:  Ravindra A Kale; Rakesh K Gupta; Vivek A Saraswat; Khader M Hasan; Richa Trivedi; Asht M Mishra; Piyush Ranjan; Chandra M Pandey; Ponnada A Narayana
Journal:  Hepatology       Date:  2006-04       Impact factor: 17.425

9.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra.

Authors:  S W Provencher
Journal:  Magn Reson Med       Date:  1993-12       Impact factor: 4.668

10.  Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia.

Authors:  Gwenaëlle Douaud; Stephen Smith; Mark Jenkinson; Timothy Behrens; Heidi Johansen-Berg; John Vickers; Susan James; Natalie Voets; Kate Watkins; Paul M Matthews; Anthony James
Journal:  Brain       Date:  2007-08-13       Impact factor: 13.501

View more
  22 in total

1.  Gut microbial RNA and DNA analysis predicts hospitalizations in cirrhosis.

Authors:  Jasmohan S Bajaj; Leroy R Thacker; Andrew Fagan; Melanie B White; Edith A Gavis; Phillip B Hylemon; Robert Brown; Chathur Acharya; Douglas M Heuman; Michael Fuchs; Swati Dalmet; Masoumeh Sikaroodi; Patrick M Gillevet
Journal:  JCI Insight       Date:  2018-03-08

2.  Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial.

Authors:  Jasmohan S Bajaj; Zain Kassam; Andrew Fagan; Edith A Gavis; Eric Liu; I Jane Cox; Raffi Kheradman; Douglas Heuman; Jessica Wang; Thomas Gurry; Roger Williams; Masoumeh Sikaroodi; Michael Fuchs; Eric Alm; Binu John; Leroy R Thacker; Antonio Riva; Mark Smith; Simon D Taylor-Robinson; Patrick M Gillevet
Journal:  Hepatology       Date:  2017-10-30       Impact factor: 17.425

3.  Hepatic Encephalopathy Is Associated with Persistent Learning Impairments Despite Adequate Medical Treatment: A Multicenter, International Study.

Authors:  Silvia Nardelli; Sanath Allampati; Oliviero Riggio; Kevin D Mullen; Ravi Prakash; Stefania Gioia; Ariel Unser; Melanie B White; Andrew C Fagan; James B Wade; Alessio Farcomeni; Edith A Gavis; Jasmohan S Bajaj
Journal:  Dig Dis Sci       Date:  2016-12-30       Impact factor: 3.199

Review 4.  Changing Epidemiology of Cirrhosis and Hepatic Encephalopathy.

Authors:  Jeremy Louissaint; Sasha Deutsch-Link; Elliot B Tapper
Journal:  Clin Gastroenterol Hepatol       Date:  2022-08       Impact factor: 13.576

Review 5.  Specific Challenges in Geriatric Cirrhosis and Hepatic Encephalopathy.

Authors:  Jasmohan S Bajaj; Angela Gentili; James B Wade; Michael Godschalk
Journal:  Clin Gastroenterol Hepatol       Date:  2022-08       Impact factor: 13.576

6.  Cognitive reserve is a resilience factor for cognitive dysfunction in hepatic encephalopathy.

Authors:  Piero Amodio; Sara Montagnese; Giuseppe Spinelli; Sami Schiff; Daniela Mapelli
Journal:  Metab Brain Dis       Date:  2017-06-02       Impact factor: 3.584

Review 7.  Neuroimaging in alcohol use disorder: From mouse to man.

Authors:  Michael Fritz; Anna M Klawonn; Natalie M Zahr
Journal:  J Neurosci Res       Date:  2019-04-22       Impact factor: 4.164

8.  Focused Education Increases Hepatocellular Cancer Screening in Patients with Cirrhosis Regardless of Functional Health Literacy.

Authors:  Jawaid Shaw; Kavish R Patidar; Bradley Reuter; Navid Hajezifar; Narayan Dharel; James B Wade; Jasmohan S Bajaj
Journal:  Dig Dis Sci       Date:  2020-09-05       Impact factor: 3.487

Review 9.  Hepatic Encephalopathy: From Metabolic to Neurodegenerative.

Authors:  Rafael Ochoa-Sanchez; Farzaneh Tamnanloo; Christopher F Rose
Journal:  Neurochem Res       Date:  2021-06-15       Impact factor: 3.996

Review 10.  Role of bile acids in liver diseases mediated by the gut microbiome.

Authors:  Jun-Wei Shao; Tian-Tian Ge; Sen-Zhong Chen; Gang Wang; Qin Yang; Chun-Hong Huang; Li-Chen Xu; Zhi Chen
Journal:  World J Gastroenterol       Date:  2021-06-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.